Abstract
The purpose of this theoretical study was to investigate the molecular features of some structurally unusual calcium antagonists with experimentally proved affinity to the diltiazem-binding site at L-type calcium channels. Therefore, sterical and electronic characteristics of cis-/trans-diclofurime, the verapamil-like derivatives McN-5691 and McN-6186 as well as the natural products papaverine, laudanosine, antioquine and tetrandrine were compared with the pharmacophoric requirements detected for classical diltiazem-like derivatives. This yielded a common pharmacophore model for all of these compounds. Based on this model, one single negative molecular electrostatic potential induced by the free electron pairs of the oxime oxygen of trans-diclofurime was detected that might be responsible for the stronger effects compared to the cis isomer. Furthermore, the dual diltiazem- and verapamil-like features of McN-5691 (and McN-6186) as well as the distinct pharmacophoric assignment of the laudanosine enantiomers may be interpreted on a molecular level. Finally, the crucial partial structure of the bis-benzylisoquinoline derivatives antioquine and tetrandrine being responsible for the calcium antagonistic effects could be revealed by superposition on the most active benzothiazepinone derivative 8-methoxydiltiazem. The results obtained for these unusual diltiazem mimics are discussed taking into consideration earlier findings for classical diltiazem-like derivatives.
Similar content being viewed by others
References
Striessnig, J., Grabner, M., Mitterdorfer, J., Hering, S., Sinnegger, M.J. and Glossmann, H., Trends Pharmacol. Sci., 19 (1998) 108.
Tanabe, T., Mikami, A., Niidome, T., Numa, S., Adams, B.A. and Beam, K.G., Ann. N.Y. Acad. Sci., 707 (1993) 81.
Kimball, S.D., Floyd, D.M., Das, J., Hunt, J.T., Krapcho, J., Rovnyak, G., Duff, K.J., Lee, V.G., Moquin, R.V., Turk, C.F., Hedberg, S.A., Moreland, S., Brittain, R.J., McMullen, D.M., Normandin, D.E. and Cucinotta, G.G., J. Med. Chem., 35 (1992) 780.
Campiani, G., Fiorini, I., De Filippis, M.P., Ciani, S.M., Garofalo, A., Nacci, V., Giorgi, G., Sega, A., Botta, M., Chiarini, A., Budriesi, R., Bruni, G., Romeo, M.R., Manzoni, C. and Mennini, T., J. Med. Chem., 39 (1996) 2922.
Campiani, G., Garofalo, A., Fiorini, I., Botta, M., Nacci, V., Tafi, A., Chiarini, A., Budriesi, R., Bruni, G. and Romeo, M.R., J. Med. Chem., 38 (1995) 4393.
Barrish, J.C., Spergel, S.H., Moreland, S., Grover, G., Hedberg, S.A., Pudzianowski, A.T., Gougoutas, J.Z. and Malley, M.F., Bioorg. Med. Chem., 1 (1993) 309.
Schleifer, K.-J. and Tot, E., Pharm. Res., 16 (1999) 1506.
Anselmi, E., Fayos, G., Blasco, R., Candenas, L., Cortes, D. and D'Ocon, P., J. Pharm. Pharmacol., 44 (1992) 337.
King, V.F., Garcia, M.L., Himmel, D., Reuben, J.P., Lam, Y-k.T., Pan, J-x., Han, G-q. and Kaczorowski, G.J., J. Biol. Chem., 263 (1988) 2238.
Liu, Q.-Y., Karpinski, E., Rao, M.-R. and Pang, P.K.T., Neuropharmacology, 30 (1991) 1325.
D'Ocon, M.P., Candenas, M.L., Anselmi, E., Zafra-Polo, M.C. and Cortes, D., Arch. Int. Pharmacodyn. Ther., 297 (1989) 205.
Spedding, M., Gittos, M. and Mir, A.K., J. Cardiovasc. Pharmacol., 9 (1987) 461.
Mir, A.K. and Spedding, M., J. Cardiovasc. Pharmacol., 9 (1987) 469.
Flaim, S.F., Gleason, M.M., Hedberg, A., Shank, R.P., McCullough, J.R., Gill, A., Damiano, B.P., Brannan, M.D. and Carson, J.R., J. Pharmacol. Exp. Ther., 256 (1991) 279.
Cambridge Structural Database, Cambridge Crystallographic Data Center, Cambridge, U.K.
Allen, F.H., Kennard, O. and Watson, D.G., Struct. Correl., 1 (1994) 71.
Gilmore, C.J., Bryan, R.F. and Kupchan, S.M., J. Am. Chem. Soc., 98 (1976) 1947.
SYBYL v. 6.5, Tripos Associates, Inc., St. Louis, MO, U.S.A.
Mazzo, D.J., Obetz, C.L. and Shuster, J., Anal. Profiles Drug Subst. Excipients, 23 (1994) 53.
Floyd, D.M., Kimball, S.D., Krapcho, J., Das, J., Turk, C.F., Moquin, R.V., Lago, M.W., Duff, K.J., Lee, V.G., White, R.E., Ridgewell, R.E., Moreland, S., Brittain, R.J., Normandin, D.E., Hedberg, S.A. and Cucinotta, G.G., J. Med. Chem., 35 (1992) 756.
Boström, J., Norrby, P.-O. and Liljefors, T., J. Comput.-Aided Mol. Design, 12 (1998) 383.
IXGROS, part of Ph.D. Thesis, Sippl, W., Düsseldorf, Germany, 1997.
Dewar, M.J.S., Zoebisch, E.G., Healy, E.F. and Stewart, J.J.P., J. Am. Chem. Soc., 107 (1985) 3902.
SPARTAN 4.1.1, Wavefunction, Irvine, CA, U.S.A.
Rampe, D., Skattebol, A., Triggle, D.J. and Brown, A.M., J. Pharmacol. Exp. Ther., 248 (1989) 164.
Ivorra, M.D., Chuliá, S., Lugnier, C. and D'Ocon, M.P., Eur. J. Pharmacol., 231 (1993) 165.
Chulia, S., Ivorra, M.D., Martinez, S., Elorriaga, M., Valiente, M., Noguera, M.A., Lugnier, C., Advenier, C. and D'Ocon, M.P., Br. J. Pharmacol., 122 (1997) 409.
Kettmann, V. and Höltje, H.-D., Quant. Struct.-Act. Relat., 17 (1998) 91.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schleifer, KJ., Tot, E. Pharmacophore modelling of structurally unusual diltiazem mimics at L-type calcium channels. J Comput Aided Mol Des 14, 427–433 (2000). https://doi.org/10.1023/A:1008188505899
Issue Date:
DOI: https://doi.org/10.1023/A:1008188505899